Armata Pharma (ARMP): Net earnings per share (EPS TTM)

ARMP (Armata Pharmaceuticals Inc) - company brandmark

Armata Pharmaceuticals management relies on scientific potential and external investments while drugs undergo clinical trials. This 12-month net income per share chart visualizes the results of this work, where the -7.14 level represents the current value. The business is not influenced by GDP, yet it requires expensive cold-chain logistics to preserve the properties of bacteriophages.

ARMP Armata Pharmaceuticals Earnings per share for the trailing year (07/04/2022 - 11/15/2026)

Armata Pharma - analytical breakdowns and key metrics (ARMP)

- stock price and consensus target price:
Stock Price Armata Pharmaceuticals Inc|ARMP - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Armata|ARMP - Real Price to Acquire Entire Company
- business book valuation details:
Net Assets per Single Share Armata Pharmaceuticals|ARMP - Accounting Value of Company|Market Value to Book Value Ratio armatapharma.com|ARMP - Company Assets
- debt and liquidity data:
Total Debt to Capital Armata Pharmaceuticals|ARMP - Long-Term Debt to Equity|Short-Term Debt to Capital Armata Pharmaceuticals Inc|ARMP - Company Cumulative Debt|Debt to Book Capitalization Ratio Armata Pharmaceuticals|ARMP - Long-Term Debt Volume|Company Short-Term Debts Armata Pharmaceuticals|Quick Liquidity armatapharma.com
- earnings and multiples data:
ARMP - Final Profit|Expected Profit Armata Pharmaceuticals|ARMP - Price to Earnings Ratio|Forward P/E Multiple Armata Pharmaceuticals Inc|ARMP - PEG Multiple|Enterprise Value to EBITDA Ratio Armata Pharmaceuticals, Inc.|ARMP - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Armata Pharmaceuticals|ARMP - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months armatapharma.com|ARMP - Earnings per share increase in current year|Net earnings per share growth forecast for next year Armata Pharmaceuticals
- issuer revenue and sales details:
ARMP - Company Annual Revenue|Projected Sales Volume Armata Pharmaceuticals, Inc.|ARMP - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Armata Pharmaceuticals Inc
Basic company analysis:ARMP - Armata Pharmaceuticals Inc
Manufactured products of Armata Pharmaceuticals Inc

Since Armata Pharmaceuticals' bacteriophage development does not yet generate revenue, the company's pricing power is limited by the clinical trial stage. The current value of -7.14 reflects the trailing twelve-month net income per share, allowing investors to filter out market noise and assess the business's actual capital by analyzing the trailing annual EPS trend to identify undervaluation points.

Competitors of Armata Pharmaceuticals

Acurx Pharmaceuticals Inc. - Net earnings per share (EPS TTM)